21.94
-0.64 (-2.83%)
| Previous Close | 22.58 |
| Open | 21.50 |
| Volume | 2,535,914 |
| Avg. Volume (3M) | 136,222 |
| Market Cap | 1,388,508,032 |
| Price / Sales | 0.970 |
| Price / Book | 7.98 |
| 52 Weeks Range | |
| Earnings Date | 3 Mar 2025 |
| Profit Margin | -6.07% |
| Operating Margin (TTM) | 4.04% |
| Diluted EPS (TTM) | -1.59 |
| Quarterly Revenue Growth (YOY) | 19.60% |
| Quarterly Earnings Growth (YOY) | 40.90% |
| Total Debt/Equity (MRQ) | 19.70% |
| Current Ratio (MRQ) | 1.14 |
| Operating Cash Flow (TTM) | 66.86 M |
| Levered Free Cash Flow (TTM) | 96.43 M |
| Return on Assets (TTM) | -12.35% |
| Return on Equity (TTM) | -59.24% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | Guardian Pharmacy Services, Inc | Bullish | - |
AIStockmoo Score
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | 0.75 |
|
Guardian Pharmacy Services Inc is a leading, highly differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs, and .BHFs. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Core |
| % Held by Insiders | 15.09% |
| % Held by Institutions | 44.61% |
| 52 Weeks Range | ||
| Median | 28.00 (27.62%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Truist Securities | 19 May 2025 | 28.00 (27.62%) | Buy | 26.52 |
| 11 Apr 2025 | 25.00 (13.95%) | Buy | 22.87 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |